다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Qualigen Therapeutics Inc (QLGN)
Qualigen Therapeutics Inc (QLGN) 뉴스

QLGN

Qualigen Therapeutics (QLGN)

Qualigen Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:QLGN

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/15	05:05	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/05/04	09:59	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/04/16	20:00	GlobeNewswire Inc.	Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/04/10	21:00	GlobeNewswire Inc.	Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer Research (AACR) 2024 Annual Meeting	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/04/09	21:00	GlobeNewswire Inc.	Qualigen Therapeutics Announces Poster Featuring Positive Early Clinical Experience with QN-302, a Novel First-in-Class G-Quadruplex Experimental Anti-Cancer Drug, at the American Association of Cancer Research (AACR) 2024 Annual Meeting	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/02/27	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2024/02/23	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2023/12/08	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2023/11/23	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2023/11/15	06:30	GlobeNewswire Inc.	Qualigen Therapeutics Provides Corporate Update for Third Quarter and To Date 2023	NASDAQ:QLGN	Qualigen Therapeutics Inc
2023/11/09	04:16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2023/11/07	22:30	GlobeNewswire Inc.	Qualigen Therapeutics Announces First Patient Dosed in the Phase 1a Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors	NASDAQ:QLGN	Qualigen Therapeutics Inc
2023/10/23	21:30	GlobeNewswire Inc.	Poster Highlighting Qualigen Therapeutics' Pan-RAS Inhibitor Platform Presented at AACR Special Conference: Advances in Breast Cancer	NASDAQ:QLGN	Qualigen Therapeutics Inc
2023/10/17	21:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2023/09/29	05:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2023/09/27	21:30	GlobeNewswire Inc.	Qualigen Therapeutics Presents Scientific Data on QN-302 at AACR Special Conference: Pancreatic Cancer 2023	NASDAQ:QLGN	Qualigen Therapeutics Inc
2023/09/08	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:QLGN	Qualigen Therapeutics Inc
2023/09/02	05:15	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:QLGN	Qualigen Therapeutics Inc
2023/08/17	21:30	GlobeNewswire Inc.	Qualigen Therapeutics Partners with TD2 for Phase 1 Clinical Development of QN-302 for the Treatment of Advanced or Metastatic Solid Tumors	NASDAQ:QLGN	Qualigen Therapeutics Inc
2023/08/15	23:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2023/08/15	21:30	GlobeNewswire Inc.	Qualigen Therapeutics, Inc. Reports Financial Results and Corporate Update for Quarter Ending June 30, 2023	NASDAQ:QLGN	Qualigen Therapeutics Inc
2023/08/15	05:16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:QLGN	Qualigen Therapeutics Inc
2023/08/05	05:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2023/08/01	21:35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2023/08/01	21:30	GlobeNewswire Inc.	Qualigen Therapeutics Announces US FDA IND Clearance to Initiate Phase 1 Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors	NASDAQ:QLGN	Qualigen Therapeutics Inc
2023/07/27	06:25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2023/07/24	21:15	GlobeNewswire Inc.	Qualigen Therapeutics Divests FastPack® Diagnostics Business	NASDAQ:QLGN	Qualigen Therapeutics Inc
2023/07/14	06:29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:QLGN	Qualigen Therapeutics Inc
2023/07/08	06:08	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	NASDAQ:QLGN	Qualigen Therapeutics Inc
2023/06/27	06:25	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:QLGN	Qualigen Therapeutics Inc

검색 관련기사 보기:NASDAQ:QLGN

1 2 3 4 5 6 7 다음 >>

Invesco QQQ Trust Series 1

US Dollar vs Sterling

Verizon Communications

Energy Select Sector SPDR

American Express

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관